Author: Hayley

Industry Growth Program Grant Announcement

Gelomics Awarded $948K Industry Growth Program Grant to Accelerate Commercialisation of AI-Powered 3D Tissue Culture Platform. 4 June 2025 Gelomics is proud to announce the award of $948,066 in non-dilutive grant funding through the Industry Growth Program under the Commercialisation and Growth stream. The $1.9 million project will fast-track the commercialisation of Gelomics’ next-generation AI-assisted […]

Gelomics Partners with SLS to Expand 3D Tissue Culture Access Across the UK and Ireland

Gelomics is proud to announce a strategic distribution partnership with Scientific Laboratory Supplies (SLS), the United Kingdom’s largest independent supplier of laboratory products. Under this agreement, SLS will serve as Gelomics’ exclusive distributor in the UK and Ireland, significantly expanding access to our advanced 3D tissue culture systems for researchers across the region. Empowering Researchers […]

Gelomics Expands Global Presence with New Distribution Partner, Voden Medical In Italy

Gelomics proudly announces a strategic partnership with Voden Medical. Voden Medical is a renowned provider of advanced diagnostic and life science solutions in Italy. Under this agreement, Voden Medical will serve as Gelomics’ exclusive distributor in the Italian market. This partnership, effective January 2025, marks a significant step forward in Gelomics’ mission to bring our […]

Conference | Join Gelomics at AACR 2025 in Chicago

We’re excited to showcase our latest innovations in 3D cell culture at AACR this April. If you’re attending, let’s connect! Schedule a meeting with our team to explore how our technology can accelerate your cancer research. 📅 April 25-30, 2025 📍 Booth #444, McCormick Place Convention Center Chicago, Illinois 🔗 Schedule a meeting today: info@gelomics.com View other events […]

On-demand Seminar | LunaGel™ Transforming 3D Cell Culture for Biomedical Breakthroughs

Discover the future of biomedical research with LunaGel™, an innovative 3D cell culture platform by Gelomics. Join Dr. Christoph Meinert, CEO of Gelomics, for an exclusive seminar exploring how LunaGel™ is revolutionizing the creation of realistic human tissue models—bridging the gap between traditional cell culture systems and cutting-edge research. Learn how LunaGel™ empowers researchers with: Dr. Meinert […]

Gelomics partners with Bucher Biotec AG for Product Distribution in Switzerland

Gelomics is pleased to announce a new strategic partnership with Bucher Biotec AG, a leading provider of advanced life science solutions in Switzerland & Lichtenstein. Under this agreement, Bucher Biotec will serve as Gelomics’ exclusive distributor across the Swiss market. This partnership marks an important milestone for Gelomics as we expand our presence in Europe. […]